Pestronk Lab

Research interests: Neuromuscular disorders

Clinical interests: Clinical neurology, neuromuscular disease, neuroimmunology, glycolipids, proteoglycans, aging and the nervous system, history of neurology, myopathy, neuropathy, weakness, myasthenia, muscle, nerve, numbness, sensory loss, pain, fatigue, muscular dystrophy, neuro muscular.

Learn more on the Neuromuscular Disease Center website »

Principal investigator

Alan Pestronk, MD

Professor, Neurology
Professor, Pathology
Director, Neuromuscular Clinical Laboratory

• Phone: 314-362-6981

  Pestronk lab

Recent publications

• Sarcoidosis, granulomas and myopathy syndromes: A clinical-pathology review
  December 15, 2022
  Sarcoidosis, granulomas and myopathy syndromes: A clinical-pathology reviewGarret, M. & Pestronk, A., Dec 15 2022, In: Journal of Neuroimmunology. 373, 577975.Research output: Contribution to journal › Article › peer-review
• Water T2 could predict functional decline in patients with dysferlinopathy
  December 1, 2022
  Water T2 could predict functional decline in patients with dysferlinopathyThe Jain COS Consortium, Dec 2022, In: Journal of Cachexia, Sarcopenia and Muscle. 13, 6, p. 2888-2897 10 p.Research output: Contribution to journal › Article › peer-review
• Randomized phase 2 study of ACE-083, a muscle-promoting agent, in facioscapulohumeral muscular dystrophy
  July 1, 2022
  Randomized phase 2 study of ACE-083, a muscle-promoting agent, in facioscapulohumeral muscular dystrophyStatland, J. M., Campbell, C., Desai, U., Karam, C., Díaz-Manera, J., Guptill, J. T., Korngut, L., Genge, A., Tawil, R. N., Elman, L., Joyce, N. C., Wagner, K. R., Manousakis, G., Amato, A. A., Butterfield, R. J., Shieh, P. B., Wicklund, M., Gamez, J., Bodkin, C., Pestronk, A., & 9 othersWeihl, C. C., Vilchez-Padilla, J. J., Johnson, N. E., Mathews, K. D., Miller, B., Leneus, A., Fowler, M., van de Rijn, M. & Attie, K. M., Jul 2022, In: Muscle and Nerve. 66, 1, p. 50-62 13 p.Research […]
• Randomized Phase 2 Study of ACE-083 in Patients With Charcot-Marie-Tooth Disease
  June 7, 2022
  Randomized Phase 2 Study of ACE-083 in Patients With Charcot-Marie-Tooth DiseaseThomas, F. P., Brannagan, T. H., Butterfield, R. J., Desai, U., Habib, A. A., Herrmann, D. N., Eichinger, K. J., Johnson, N. E., Karam, C., Pestronk, A., Quinn, C., Shy, M. E., Statland, J. M., Subramony, S. H., Walk, D., Stevens-Favorite, K., Miller, B., Leneus, A., Fowler, M., Van De Rijn, M., & 1 othersAttie, K. M., Jun 7 2022, In: Neurology. 98, 23, p. E2356-E2367Research output: Contribution to journal › Article › peer-review
• Cardiac and pulmonary findings in dysferlinopathy: A 3-year, longitudinal study
  May 1, 2022
  Cardiac and pulmonary findings in dysferlinopathy: A 3-year, longitudinal studyThe Jain COS Consortium, May 2022, In: Muscle and Nerve. 65, 5, p. 531-540 10 p.Research output: Contribution to journal › Article › peer-review